On August 27, 2025, Angels for Change was featured at the Reagan-Udall Foundation for the FDA’s Public Meeting on Demand Forecasting for Controlled Substances in Washington, DC. Our founder, Laura Bray, was a featured panelist.
In our public comments for the record, we highlighted how outdated and inflexible forecasting processes are leaving patients without access to critical medicines. We called for a more transparent, patient-centered approach that:
Anchors demand forecasting in real-world patient care rather than sales data
Brings together stakeholders across the supply chain, prescribers, and patient advocates
Builds regulatory flexibility to respond to changing patient needs
“We must anchor forecasting in patient care, reimbursement realities, and supply chain insight — not in sales numbers skewed by a constrained, quota-driven market.”
The panel discussion, moderated by Susan Winkler CEO of the Reagan-Udall foundation, brought together leaders from across healthcare to examine the challenges of forecasting controlled substances, the importance of accurate data, and the broader impact on patient access.
Read our full public comments submitted during the meeting below.